Skip to the main content

Philips Ventures

North Holland Founded 2016 Website LinkedIn
Cheque Size$2M to $5M
Stages3
Industries15
Markets21
Stated Portfolio4
Operating Since2016 (10y)

About Philips Ventures

Philips Ventures is the corporate venture capital arm of Philips, focusing on investments in health technology companies. They specialize in early- and growth-stage investments in healthcare technology companies addressing unmet needs that align with Philips’ businesses. Their portfolio includes direct investments and business-sponsored collaborations, aiming to drive innovation in healthcare. Their investment strategy targets health technology opportunities, emphasizing partnerships based on Philips' current priority areas where joint innovation can make the biggest impact. They work with start-ups and Philips to create mutually beneficial strategic relationships that address specific healthcare challenges. Their team is committed to being an active champion of their start-up collaborators, driving long-term commercial relationships. Philips Ventures has been recognized as the Most Prolific Corporate VC for investing in future Philips partners through their business agnostic digital health fund. They have made over 10 direct digital health investments and executed over 20 business-sponsored investments and collaborations between start-ups and Philips businesses, resulting in new solutions across their product portfolio. Their team is based across the world in hubs including Eindhoven, Amsterdam, Cambridge Massachusetts, Bangalore, and Shanghai, acting as champions for start-ups within Philips.

Geographical Focus

African markets1

Other stated markets20

United StatesUnited KingdomCanadaGermanyJapanAustraliaSingaporeChinaIndiaBrazilFranceItalyUnited Arab EmiratesSpainMexicoSouth KoreaSaudi ArabiaNetherlandsRussiaMalaysia

Requirements

Seed level to Series B, with a validated solution, Alignment with Philips' current focus areas, Experienced founders with the capacity to bring about real change

Stated Portfolio4

Mytonomy
Noninvasix
3Derm
Common Sensing

As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.